Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.96M Buy
10,939
+324
+3% +$111K 0.05% 241
2026
Q1
$3.73M Buy
10,615
+154
+1% +$54.9K 0.05% 225
2025
Q4
$3.42M Sell
10,461
-216
-2% -$68.5K 0.05% 234
2025
Q3
$3.01M Sell
10,677
-6,677
-38% -$1.94M 0.05% 243
2025
Q2
$4.85M Buy
17,354
+8,563
+97% +$2.43M 0.08% 160
2025
Q1
$2.74M Buy
8,791
+2,775
+46% +$819K 0.05% 188
2024
Q4
$1.57M Buy
6,016
+176
+3% +$52.2K 0.03% 260
2024
Q3
$1.88M Buy
5,840
+672
+13% +$220K 0.04% 199
2024
Q2
$1.61M Buy
5,168
+254
+5% +$74.6K 0.04% 205
2024
Q1
$1.4M Buy
4,914
+303
+7% +$88.7K 0.04% 222
2023
Q4
$1.33M Buy
4,611
+1,264
+38% +$344K 0.04% 214
2023
Q3
$900K Sell
3,347
-7
-0.2% -$1.75K 0.03% 264
2023
Q2
$745K Buy
3,354
+275
+9% +$63.8K 0.02% 295
2023
Q1
$744K Sell
3,079
-95
-3% -$23.3K 0.02% 315
2022
Q4
$834K Buy
3,174
+80
+3% +$21.4K 0.03% 296
2022
Q3
$697K Sell
3,094
-36
-1% -$8.73K 0.03% 245
2022
Q2
$761K Buy
3,130
+2,016
+181% +$494K 0.04% 250
2022
Q1
$270K Sell
1,114
-109
-9% -$25K 0.01% 404
2021
Q4
$275K Sell
1,223
-1,894
-61% -$400K 0.01% 383
2021
Q3
$663K Buy
3,117
+2,040
+189% +$470K 0.03% 254
2021
Q2
$262K Buy
1,077
+41
+4% +$10.1K 0.01% 333
2021
Q1
$258K Sell
1,036
-2,140
-67% -$511K 0.01% 329
2020
Q4
$730K Buy
3,176
+2,332
+276% +$538K 0.04% 227
2020
Q3
$215K Buy
+844
New +$209K 0.02% 324
2020
Q2
Sell
-1,045
Closed -$212K 306
2020
Q1
$212K Sell
1,045
-816
-44% -$178K 0.02% 254
2019
Q4
$449K Buy
1,861
+614
+49% +$135K 0.03% 203
2019
Q3
$241K Sell
1,247
-781
-39% -$150K 0.02% 251
2019
Q2
$374K Buy
2,028
+28
+1% +$5.01K 0.03% 202
2019
Q1
$380K Buy
2,000
+8
+0.4% +$1.53K 0.03% 202
2018
Q4
$388K Buy
1,992
+50
+3% +$9.76K 0.05% 103
2018
Q3
$403K Hold
1,942
0.04% 128
2018
Q2
$358K Buy
1,942
+125
+7% +$22.1K 0.03% 125
2018
Q1
$310K Sell
1,817
-20
-1% -$3.67K 0.03% 126
2017
Q4
$319K Sell
1,837
-95
-5% -$16.8K 0.05% 78
2017
Q3
$360K Buy
1,932
+678
+54% +$120K 0.06% 57
2017
Q2
$216K Sell
1,254
-2,013
-62% -$327K 0.04% 63
2017
Q1
$536K Buy
+3,267
New +$543K 0.1% 48
2016
Q4
Sell
-1,519
Closed -$253K 88
2016
Q3
$253K Buy
1,519
+10
+0.7% +$1.69K 0.06% 68
2016
Q2
$246K Buy
+1,509
New +$235K 0.08% 52
2015
Q2
Sell
-2,091
Closed -$329K 38
2015
Q1
$329K Sell
2,091
-50
-2% -$7.88K 0.35% 19
2014
Q4
$341K Hold
2,141
0.37% 20
2014
Q3
$301K Buy
2,141
+138
+7% +$18K 0.38% 16
2014
Q2
$229K Hold
2,003
0.41% 10
2014
Q1
$229K Hold
2,003
0.45% 8
2013
Q4
$229K Buy
+2,003
New +$228K 1.88% 4

Other funds holding AMGN

Miracle Mile Advisors's AMGN Position: Q2 2026 in Review

Miracle Mile Advisors increased its Amgen (AMGN) stake by 3.1% in Q2 2026, buying an estimated $111K and bringing the position to 10,939 shares worth $3.96M. The position accounts for 0.05% of the portfolio, ranked #241.

Miracle Mile Advisors first reported a position in AMGN in Q4 2013 and has held it in 45 quarters since. The position peaked at $4.85M in Q2 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Miracle Mile Advisors held 10,939 shares of Amgen worth $3.96M as of Q2 2026.
  • Miracle Mile Advisors bought 324 Amgen shares in Q2 2026, an estimated $111K.
  • Amgen made up 0.05% of Miracle Mile Advisors's portfolio in Q2 2026, its #241 holding.
  • Miracle Mile Advisors first reported a position in Amgen in Q4 2013 and has held it in 45 quarters since.
  • Miracle Mile Advisors's Amgen position peaked at $4.85M in Q2 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.